Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors

Authors not listed

Case Comprehensive Cancer Center · 2026

Abstract

The purpose of this research study is to investigate whether cancer survivors have higher levels of proteins called Fatty Acid Binding Proteins as well as 12 different markers of cellular senescence(definition) than people who have never had cancer. Investigators believe that these levels may be elevated in cancer survivors as a result of their cancer and the treatments they received and may put them at higher risk for chronic conditions such as high cholesterol, diabetes, high blood pressure, and obesity. This study will also compare the levels of these proteins and inflammatory markers in the blood with different aspects of cancer treatment the survivors received. Investigators are investigating if there is a correlation between levels of these proteins and markers, the type of treatment cancer survivors received, and development of metabolic conditions.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2026). Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors. <em>Case Comprehensive Cancer Center</em>. https://clinicaltrials.gov/study/NCT07114614
Vancouver
Anonymous. Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors. Case Comprehensive Cancer Center. 2026.
BibTeX
@misc{anon2026FattyA, title = {Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors}, author = {Anonymous}, journal = {Case Comprehensive Cancer Center}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings